Publication | Closed Access

Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma

Tumor BiologyUrologyMtor InhibitorsMedicinePharmacologyRetinoblastoma ProteinCancer BiologyMevalonate Pathway BlockageTumor SuppressorAnti-cancer AgentOncologyCancer Research